000 01435 a2200397 4500
005 20250515191427.0
264 0 _c20110203
008 201102s 0 0 spa d
022 _a0025-7753
024 7 _a10.1016/j.medcli.2009.08.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRodriguez-Pecci, MarĂ­a Soledad
245 0 0 _a[Mirtazapine-associated hepatotoxicity].
_h[electronic resource]
260 _bMedicina clinica
_cNov 2010
300 _a625-6 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntidepressive Agents
_xadministration & dosage
650 0 4 _aChemical and Drug Induced Liver Injury
_xetiology
650 0 4 _aCholestasis
_xchemically induced
650 0 4 _aDepressive Disorder
_xcomplications
650 0 4 _aDrug Interactions
650 0 4 _aDuloxetine Hydrochloride
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xcomplications
650 0 4 _aMale
650 0 4 _aMianserin
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aMirtazapine
650 0 4 _aNephrosclerosis
_xcomplications
650 0 4 _aThiophenes
_xadministration & dosage
700 1 _aFuente-Aguado, Javier de la
700 1 _aMontero-Tinnirello, Javier
700 1 _aFernandez-Fernandez, Francisco J
773 0 _tMedicina clinica
_gvol. 135
_gno. 13
_gp. 625-6
856 4 0 _uhttps://doi.org/10.1016/j.medcli.2009.08.002
_zAvailable from publisher's website
999 _c19215978
_d19215978